COMPREHENSIVE MEDICAL SERVICES Platform FOR YOUR PATIENTS
offered by offer wellness
Schedule a webinar with Offer Wellness for more information on how to add this to your patient population.
The Offer Wellness HRV Wave Device can be a tremendous tool for primary care doctors in their fight to prevent cardiovascular disease in patient populations.
The First Highly Accurate System to Test a Patient’s Level of Homeostasis, Heart Rate Variability (HRV) and Other Essential Medical Tests in a Primary Care Setting.
In just 8 minutes, the HRV Wave Device provides a complete series of test results that primary care practices can use to diagnose and treat various conditions.
The HRV Wave can also test for the early and late stage of
• Cardiovascular disease
• Peripheral and Arterial Elasticity
• Arterial blockages
• Heart rate variability (HRV) dysfunction
• Blood Pressure Instability (PAD)
• Mental and physical stress
• Fatigue issues (Sleeplessness)
The HRV Wave Device also provides an extremely accurate and documented assessment of the effectiveness of most medications and treatments for these conditions.
HRV WAVE DEVICE
FDA Approved Medical Devices
We supply several “state of the art” FDA-approved medical devices that test for “Homeostasis” and “Sympathetic Dominance” using HRV and Pulse Wave Velocity technologies. The devices can also test for cardiovascular disease and neuropathy. These level one tests take about 8 minutes to complete with immediate tests results.
Lp-PLA2 (PLAC®) Test
LDL carries Lp-PLA2 to the coronary artery walls where it activates an inflammatory response. This makes plaque, if present, more prone to rupture. Because this enzyme is associated with causing inflammation of coronary artery walls, high levels of Lp-PLA2 would therefore seem to indicate an increased risk of heart attack or stroke.
As a result, the PLAC Test, which is measuring levels of Lp-PLA2, serves as a specific independent coronary marker.
The PLAC Test measures Lp-PLA2 activity quantitatively.
Given that the majority of heart attacks and strokes are caused by plaque rupture and thrombosis, rather than a narrowing of the arteries, it would seem that individuals with high levels of Lp-PLA2 might benefit from more aggressive management with therapeutic intervention and/or lifestyle modification.
Lipid levels alone cannot provide a great deal of information on the status of the artery wall whereas Lp-PLA2 is a direct measure of artery wall enzyme activity, independent of other cardiovascular markers.
It is not intended that the PLAC Test should replace blood lipid testing or other traditional risk factors identified for cardiovascular disease. It provides an additional independent risk marker.
The PLAC test is recommended for patients with known CVD disease or specific signs of atherosclerosis through pulse wave velocity testing (HRV Wave Testing).
High levels of Lp-PLA2 are consistently linked to higher risk of heart attack and stroke in multiple population-based studies*
Further investigations using other independent cardiovascular biomarkers (Apo B, Lp(a), etc.) as well as periodic HRV Wave testing should be performed to build a patient history of overall arterial health.
Insurance and Billing
We accept most major insurance plans and offer a variety of payment options to make it easy for you to pay for your medical care. Our billing team is always available to answer your questions and help you navigate the insurance process.
early warning signs for heart disease and stroke
offered by offer wellness
Schedule a webinar with Offer Wellness for more information on how to add this to your patient population.